Literature DB >> 4118046

Appearance and persistence of antibodies against different virus components after regular measles infections.

E Norrby, Y Gollmar.   

Abstract

Different measles virus-specific antibody activities in acute, early (11 to 40 days after rash) and late (4 to 20 years postinfection) convalescent sera and gamma globulin were determined. Early immunoglobulin G antibodies gave a poor neutralization, which was increased 10- to 60-fold by addition of anti-gamma globulin. There was a high degree of correlation between titers of hemolysis-inhibiting (HLI) and hemagglutinating-inhibiting (HI) antibodies. However, in one out of fifteen late convalescent sera an HLI antibody titer of 640 in the presence of titer of only 20 in HI tests with Tween 80-either-treated antigen was found. Similar findings were made with sera from two patients with multiple sclerosis included in a parallel study. A somewhat higher titer of HI antibodies was demonstrable in these three sera when untreated material was used as antigen. These findings are interpreted in the following way. Antibodies against the hemagglutinin can block not only virus-specific agglutination but also lysis of red cells. In contrast, antibodies against the hemolysin, besides blocking the biological activity of this component, carry only a slight HI activity. This HI activity can be detected only by use of antigen preparations containing hemagglutinin-associated hemolysin.Complement-fixation (CF) and immunodiffusion tests (the latter were carried out with antigen preparations treated with 0.25% sodium dodecyl sulfate) demonstrated that, in almost all cases, antibodies against nucleocapsid structures dominated quantitatively among antibodies appearing in connection with and persisting after regular measles infections. Generally, only low titers of antibodies reacting with purified small particle hemagglutinin (HA; 10 to 14S) or additional structural or nonstructural components were identified in CF and immunodiffusion tests.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4118046      PMCID: PMC422522          DOI: 10.1128/iai.6.3.240-247.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  26 in total

1.  Neutralization of an infectious herpes simplex virus-antibody complex by anti-gamma-globulin.

Authors:  W K Ashe; A L Notkins
Journal:  Proc Natl Acad Sci U S A       Date:  1966-08       Impact factor: 11.205

2.  Heterogeneity in the properties of 7 S and 19S rabbit-neutralizing antibodies to herpes simplex virus.

Authors:  B Hampar; A L Notkins; M Mage; M A Keehn
Journal:  J Immunol       Date:  1968-03       Impact factor: 5.422

3.  Neutralization of sensitized lactic dehydrogenase virus by anti-gammglobulin.

Authors:  A L Notkins; M Mage; W K Ashe; S Mahar
Journal:  J Immunol       Date:  1968-02       Impact factor: 5.422

4.  Gel precipitation reactions between alkaline extracted rubella antigens and human sera.

Authors:  A A Salmi
Journal:  Acta Pathol Microbiol Scand       Date:  1969

5.  Neutralization of residual infectivity of Venezuelan equine encephalomyelitis virus by anti-gamma globulin.

Authors:  N Hahon
Journal:  J Gen Virol       Date:  1970-03       Impact factor: 3.891

6.  Separation and characterization of products of two measles virus variants.

Authors:  A Chiarini; E Norrby
Journal:  Arch Gesamte Virusforsch       Date:  1970

7.  Preparation and properties of antibody directed specifically against the neuraminidase of influenza virus.

Authors:  R G Webster; W G Laver
Journal:  J Immunol       Date:  1967-07       Impact factor: 5.422

8.  Functional significance of sialidose during influenza virus multiplication.

Authors:  J T Seto; R Rott
Journal:  Virology       Date:  1966-12       Impact factor: 3.616

9.  Protective effects of specific immunity to viral neuraminidase on influenza virus infection of mice.

Authors:  J L Schulman; M Khakpour; E D Kilbourne
Journal:  J Virol       Date:  1968-08       Impact factor: 5.103

10.  Antiviral activity of antiserum specific for an influenza virus neuraminidase.

Authors:  E D Kilbourne; W G Laver; J L Schulman; R G Webster
Journal:  J Virol       Date:  1968-04       Impact factor: 5.103

View more
  42 in total

Review 1.  Negative signaling in health and disease.

Authors:  K M Coggeshall
Journal:  Immunol Res       Date:  1999       Impact factor: 2.829

2.  Measles virus (MV) nucleoprotein binds to a novel cell surface receptor distinct from FcgammaRII via its C-terminal domain: role in MV-induced immunosuppression.

Authors:  David Laine; Marie-Claude Trescol-Biémont; Sonia Longhi; Geneviève Libeau; Julien C Marie; Pierre-Olivier Vidalain; Olga Azocar; Adama Diallo; Bruno Canard; Chantal Rabourdin-Combe; Hélène Valentin
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 3.  Viruses and multiple sclerosis.

Authors:  Gregory P Owens; Don Gilden; Mark P Burgoon; Xiaoli Yu; Jeffrey L Bennett
Journal:  Neuroscientist       Date:  2011-12       Impact factor: 7.519

4.  Implication of vaccination on measles reduction and elimination in Nigeria.

Authors:  A B Onoja; K M Hamid; J A Adeniji; M D Mukhtar
Journal:  Afr J Med Med Sci       Date:  2014-09

5.  Identification of an immunodominant neutralizing and protective epitope from measles virus fusion protein by using human sera from acute infection.

Authors:  S F Atabani; O E Obeid; D Chargelegue; P Aaby; H Whittle; M W Steward
Journal:  J Virol       Date:  1997-10       Impact factor: 5.103

6.  Local synovial synthesis of oligoclonal measles virus antibodies and of smooth muscle antibodies in a case of atypical rheumatoid arthritis.

Authors:  B Vandvik; O J Mellbye; E Norrby
Journal:  Ann Rheum Dis       Date:  1977-08       Impact factor: 19.103

7.  Human HLA class I- and HLA class II-restricted cloned cytotoxic T lymphocytes identify a cluster of epitopes on the measles virus fusion protein.

Authors:  R S van Binnendijk; J P Versteeg-van Oosten; M C Poelen; H F Brugghe; P Hoogerhout; A D Osterhaus; F G Uytdehaag
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Immunoglobulin G from subacute sclerosing panencephalitis brain as an immunological reagent.

Authors:  M L Weil; E Norrby; H H Itabashi; R Wilson; W W Tourtellotte; D C Heiner
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

9.  Enzyme-linked immunosorbent assay for evaluation of immunity to measles virus.

Authors:  K A Weigle; M D Murphy; P A Brunell
Journal:  J Clin Microbiol       Date:  1984-03       Impact factor: 5.948

10.  Identification of measles virus-specific hemolysis-inihibiting antibodies separate from hemagglutination-inhibiting antibodies.

Authors:  E Norrby; Y Gollmar
Journal:  Infect Immun       Date:  1975-02       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.